UCSD Center for Pain and Palliative Care
La Jolla, California, 92037, United States
NCT Number: NCT00373893
To determine the effects of Lidocaine patch on the pain and hyperalgesia induced by intradermal capsaicin
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
La Jolla, California, 92037, United States
A randomized, double-blinded, placebo controlled methodology will be conducted. At the session subjects will be exposed to placebo patch and lidocaine patch. Prior to study drug administration, a baseline neurosensory test on the volar aspect of both forearms will be performed and baseline vital signs will be measured. A placebo patch and a lidocaine patch will then be applied to the volar aspect of each forearm. The arms will be randomized to which arm receives placebo and which one receives the lidocaine patch. After four hours of application the right forearm patch will be removed the neurosensory testing will be repeated on the right forearm. After completing the testing, capsaicin (10µl, 10 mg/ml) will be injected intradermally on the volar aspect of the right forearm. Elicited and spontaneous pain scores, blood pressure, heart rate, and respiratory rate will be measured at the time of injection and every 2.5 minutes for 10 minutes. A McGill Pain Questionnaire will be administered at the time of capsaicin injection only. Ten minutes after the capsaicin injection, the hyperalgesic area will be established to von Frey hair, stroking, and heat; the flare response will be outlined; and neurosensory testing will performed halfway between the edge of this defined area and the capsaicin injection site. At the completion of the testing on the right forearm, the left forearm patch will be removed and the procedures described for the right forearm will be repeated for the left forearm.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of California, San Diego
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04576507
Cannabis, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT01480765
Chronic Disease, Chronic Illness
London, United Kingdom
View Trial DetailsNCT01992146
Central Nervous System Sensitization, Hyperalgesia
Copenhagen, Denmark
View Trial DetailsNCT05284383
Hyperalgesia, Nervous System Diseases
Leiden, Netherlands
View Trial Details